FibroGen (FGEN) Tops Q1 EPS by 11c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.45), $0.11 better than the analyst estimate of ($0.56).

At March 31, 2016, FibroGen had $309.9 million of cash, cash equivalents, investments, receivables and restricted cash

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Cerebras Q1 EPS miss sends shares down 9% after-hours